J Odriozola

1.4k total citations
46 papers, 914 citations indexed

About

J Odriozola is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, J Odriozola has authored 46 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 13 papers in Genetics and 8 papers in Immunology. Recurrent topics in J Odriozola's work include Hematopoietic Stem Cell Transplantation (18 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). J Odriozola is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). J Odriozola collaborates with scholars based in Spain, France and United States. J Odriozola's co-authors include Jaime Pérez de Oteyza, Lucı́a Villalón, Jesús F. San Miguel, Miguel Á. Sanz, J. L. Steegmann, Jorge Sierra, Álvaro Urbano-Ispizúa, José García‐Laraña, J Garcı́a-Conde and Adrían Alegre and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

J Odriozola

45 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Odriozola Spain 15 667 269 261 192 180 46 914
Marion M. Roberts Australia 10 659 1.0× 185 0.7× 95 0.4× 313 1.6× 235 1.3× 16 856
Isabel Granada Spain 15 463 0.7× 292 1.1× 217 0.8× 135 0.7× 75 0.4× 53 870
Katsumichi Fujimaki Japan 19 419 0.6× 254 0.9× 171 0.7× 330 1.7× 153 0.8× 85 1.1k
DC Linch United Kingdom 18 497 0.7× 255 0.9× 241 0.9× 417 2.2× 241 1.3× 49 1.2k
Jolanta B. Perz Germany 14 396 0.6× 154 0.6× 402 1.5× 154 0.8× 59 0.3× 27 795
Silvana Capalbo Italy 15 289 0.4× 271 1.0× 144 0.6× 166 0.9× 179 1.0× 37 669
C Dresch France 20 665 1.0× 516 1.9× 181 0.7× 120 0.6× 166 0.9× 72 1.1k
RH van Oers Netherlands 11 317 0.5× 149 0.6× 181 0.7× 205 1.1× 404 2.2× 20 894
G. Nedellec France 13 362 0.5× 292 1.1× 204 0.8× 336 1.8× 63 0.3× 32 924
Dina Attias Israel 16 205 0.3× 215 0.8× 169 0.6× 218 1.1× 210 1.2× 46 864

Countries citing papers authored by J Odriozola

Since Specialization
Citations

This map shows the geographic impact of J Odriozola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Odriozola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Odriozola more than expected).

Fields of papers citing papers by J Odriozola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Odriozola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Odriozola. The network helps show where J Odriozola may publish in the future.

Co-authorship network of co-authors of J Odriozola

This figure shows the co-authorship network connecting the top 25 collaborators of J Odriozola. A scholar is included among the top collaborators of J Odriozola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Odriozola. J Odriozola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villuendas, Raquel, J. L. Steegmann, Marina Pollán, et al.. (2006). Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach. Leukemia. 20(6). 1047–1054. 84 indexed citations
2.
3.
Cervantes, Francisco, Juan Carlos Hernández‐Boluda, J Odriozola, et al.. (2003). Imatinib mesylate (STI571) treatment in patients with chronic‐phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation. British Journal of Haematology. 120(3). 500–504. 8 indexed citations
4.
Arranz, R., E. Condé, Francisco Rodríguez Salvanés, et al.. (2002). CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation. Bone Marrow Transplantation. 29(3). 205–211. 7 indexed citations
5.
Martino, Rodrigo, Javier de la Serna, José L. Díez‐Martín, et al.. (2002). Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant. Bone Marrow Transplantation. 30(2). 63–68. 13 indexed citations
6.
Cervera, José, Marı́a José Calasanz, José A. Martínez-Climent, et al.. (2001). Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.. PubMed. 86(8). 807–13. 49 indexed citations
7.
Wiestner, Adrian, Stephan A. Padosch, Nico Ghilardi, et al.. (2000). Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia. British Journal of Haematology. 110(1). 104–109. 29 indexed citations
8.
9.
Quirós-Roldán, Eugenia, Carmen Rodrı́guez, Jaime Pérez de Oteyza, et al.. (1999). [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].. PubMed. 113(1). 1–5. 3 indexed citations
10.
Odriozola, J, et al.. (1997). [Familial essential thrombocythemia associated with von Willebrand disease].. PubMed. 109(6). 237–237. 6 indexed citations
11.
López‐Jiménez, Javier, et al.. (1997). Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplantation. 20(3). 243–245. 14 indexed citations
12.
Oteyza, Jaime Pérez de, Pedro Ramos, Nydia G. Testa, et al.. (1997). High-dose granulocyte-colony stimulating factor (G-CSF) in vitro induces the growth of high proliferative potential colony forming cells (HPP-CFC) in patients undergoing blood stem cell mobilization.. PubMed. 25(6). 516–20. 3 indexed citations
13.
Montserrat, E, José Luis López Lorenzo, F. Manso, et al.. (1996). Fludarabine in Resistant or Relapsing B-Cell Chronic Lymphocytic LeukemiaThe Spanish GroupExperience. Leukemia & lymphoma. 21(5-6). 467–472. 41 indexed citations
14.
Quirós-Roldán, Eugenia, Carmen Rodrı́guez, Jaime Pérez de Oteyza, et al.. (1996). [Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation].. PubMed. 106(5). 169–73. 3 indexed citations
15.
16.
Lavilla, Esperanza, J Odriozola, José García‐Laraña, et al.. (1993). Interferon Alpha 2A in the Treatment of Chronic Myelogenous Leukemia in Chronic Phase. Results of the Spanish Group. Leukemia & lymphoma. 11(sup1). 175–179. 7 indexed citations
17.
Menéndez, José López, P. González-Porqué, Jaime Pérez de Oteyza, et al.. (1993). Amylase-Producing Bence Jones Multiple Myeloma with Pancreatitis-Like Symptoms. Acta Haematologica. 90(2). 99–101. 9 indexed citations
18.
García‐Laraña, José, et al.. (1993). Thalidomide as therapy for intestinal chronic GVHD.. PubMed. 11(3). 251–2. 6 indexed citations
19.
Sureda, Anna, et al.. (1990). Coincidental autoimmune hemolytic anemia and massive pulmonary hemorrhage in systemic lupus erythematosus.. PubMed. 17(2). 267–8. 6 indexed citations
20.
Sureda, Anna, et al.. (1990). Quinidine-induced Agranulocytosis of Abrupt Onset. Acta Haematologica. 84(1). 43–44. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion M. Roberts Breakdown of academic impact, for papers by Isabel Granada Breakdown of academic impact, for papers by Katsumichi Fujimaki Breakdown of academic impact, for papers by DC Linch Breakdown of academic impact, for papers by Jolanta B. Perz Breakdown of academic impact, for papers by Silvana Capalbo Breakdown of academic impact, for papers by C Dresch Breakdown of academic impact, for papers by RH van Oers Breakdown of academic impact, for papers by G. Nedellec Breakdown of academic impact, for papers by Dina Attias
Rankless by CCL
2026